NICE backs new treatment for chronic liver disease

3rd March 2017 Uncategorised 0

Intercept’s Ocaliva is being backed by the National Institute for Health and Care Excellence for routine NHS commissioning as a treatment for people with the chronic liver disease primary biliary cholangitis (PBC).
Source: News